Pacira | PCRX - Action





Action Changement Date
Astellas Pharma JPY 297.26B 9.92B 2025-03
Bristol-Myers Squibb USD 2.76B 66M 2026-03
Cara Therapeutics USD 900K 0 2025-03
Coherus Biosciences USD 3.17M 1.12M 2025-12
Heron Therapeutics USD 54.57M 2.33M 2022-12
J&J USD 14.58B 392M 2026-03
Ligand Pharmaceuticals USD 13.27M 4.14M 2026-03
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novo Nordisk DKK 45.65B 21.26B 2025-06
Omeros USD 712K 266K 2021-09
Pacira USD 150.37M 2.49M 2026-03
Perrigo USD 1.12B 27.6M 2026-03
Pfizer USD 10.67B 13M 2026-03
Supernus Pharmaceuticals USD 110.77M 1.71M 2026-03
Teva Pharmaceutical Industries USD 3.18B 144M 2025-12
Xeris Pharmaceuticals USD 74.23M 5.56M 2026-03
Zoetis USD 2.55B 120M 2026-03